Titles
- COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees1
- COVID-19 in nursing homes: CMS needs to continue to strengthen oversight of infection prevention and control : report to congressional addressees1
- COVID-19 in nursing homes: Experts identified actions aimed at improving infection prevention and control : report to congressional addressees1
- COVID-19. GAO recommendations can help federal agencies better prepare for future public health emergencies1
- COVID-19: Current and future federal preparedness requires fixes to improve health data and address improper payments : report to congressional committees1
- COVID-19: FDA took steps to help make tests available; policy for future public health emergencies needed : report to congressional addressees1
- COVID-19: Federal efforts to provide vaccines to racial and ethnic groups : report to congressional committees1
- COVID-19: HHS and DOD transitioned vaccine responsibilities to HHS, but need to address outstanding issues : report to congressional addressees1
- COVID-19: HHS funds allocated to support disproportionately affected communities : report to congressional addressees1
- COVID-19: Information on HHS's public education campaign : report to congressional committees1
- COVID-19: Pandemic lessons highlight need for public health situational awareness network : report to congressional addressees1
- COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees1
- Cancer clinical trial eligibility criteria: available therapy in non-curative settings1
- Cannabis and cannabis-derived compounds: quality considerations for clinical research : guidance for industry1
- Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic1
- Challenges with vaccination data hinder state and local immunization program efforts to combat COVID-191
- Chronic rhinosinusitis with nasal polyps: developing drugs for treatment : guidance for industry1
- Cleaner health care: hospital emissions mitigation1
- Clinical decision support software: guidance for industry and Food and Drug Administration staff1
- Clinical drug interaction studies with combined oral contraceptives: guidance for industry1